Watson CEO's Attorney Urges Court To Quash FTC Subpoena For His Testimony
This article was originally published in The Pink Sheet Daily
Executive Summary
Watson CEO Paul Bisaro claims FTC tried to force the company into deal with Apotex while FTC says it simply wants to know if Watson had a deal not to relinquish its market exclusivity.